Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

MODERNA INC (MRNA)

687 + Investors. Track Smart Money conviction in MRNA. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +48
Streak
1Q ▲
Buyers last Q
49%

Smart Money Signals — MRNA

Based on 628 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added MRNA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
📊

High ownership — 70% of 3.0Y peak

70% of all-time peak
628 funds currently hold this stock — 70% of the 3.0-year high of 897 funds (reached 2023 Q1). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📉

Outflows — 8% fewer funds vs a year ago

fund count last 6Q
53 fewer hedge funds hold MRNA compared to a year ago (-8% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🟠

More sellers than buyers — 49% buying

296 buying312 selling
Last quarter: 312 funds reduced or exited vs 296 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
📈

More new buyers each quarter (+50 vs last Q)

new funds entering per quarter
Funds opening a new MRNA position: 83 → 86 → 67 → 117. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

66% of holders stayed for 2+ years

■ 66% conviction (2yr+) ■ 19% medium ■ 15% new
413 out of 628 hedge funds have held MRNA for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +24% but shares only +9% — price-driven

Value
+24%
Shares
+8%
Last quarter: the total dollar value of institutional holdings rose +24%, but actual share count only changed +9%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
➡️

Steady discovery — ~117 new funds/quarter

119 → 83 → 86 → 67 → 117 new funds/Q
New funds entering each quarter: 83 → 86 → 67 → 117. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Deep conviction — 71% of holders stayed 2+ years

■ 71% veterans ■ 9% 1-2yr ■ 20% new
Of 687 current holders: 488 (71%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
🏆

Elite ownership — 45% AUM from top-100 funds

45% from top-100 AUM funds
42 of 628 holders are among the 100 largest funds by AUM, controlling 45% of total institutional value in MRNA. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
1.9
out of 10
Low Exit Risk
Exit risk score 1.9/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Hedge Fund Ownership: MRNA

How many hedge funds hold MRNA — quarterly history vs. share price
Quarterly hedge fund ownership of MRNA vs. share price

Market Analysis: MRNA

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: MRNA

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Smart Money Signal ?
Broad Consensus, Selective Conviction

Many quality funds hold this stock, but top-tier positions remain relatively small.

82 top-rated funds 2 high-conviction
Consensus
8.3
/ 10
breadth
×
Elite
2.2
/ 10
conviction
Hedge Fund Positioning: MRNA
2026 Q1 Stats Unlock in 11 days 687 + Investors

Track Smart Money conviction in MRNA. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 687 647 6.18%
13F Shares 388M 357M 8.64%
Total Value $11.44B $9.21B 24.22%
New Positions 118 72 +46
Increased Positions 261 289 -28
Closed Positions 75 108 -33
Reduced Positions 338 304 +34
Total Calls 36 36 -
Total Puts 37 40 -7.5%
PUT/CALL Ratio 1.03 1.11 Neutral

Statistics: MRNA

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

687 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in MRNA. Verified SEC 13F-HR filings.

Top 25 institutional holders of MRNA — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Green Alpha Advisors, LLC 1.72% 34,338 $1.7M
2 CHAPIN DAVIS, INC. 1.42% 125,539 $6.4M
3 Legal Advantage Investments, Inc. 1.26% 48,175 $2.4M
4 BAILLIE GIFFORD & CO 1.04% 19,985,876 $1.02B
5 BANQUE PICTET & CIE SA 0.98% 2,748,754 $139.6M
6 Douglas Lane & Associates, LLC 0.96% 1,311,480 $66.6M
7 PATTON FUND MANAGEMENT, INC. 0.76% 88,410 $4.5M
8 Financial Gravity Asset Management, Inc. 0.70% 77,066 $3.9M
9 Stone Wealth Partners 0.62% 13,557 $689K
10 Montaka Global Pty Ltd 0.61% 20,058 $1.0M
11 Leonteq Securities AG 0.57% 302,375 $15.4M
12 Friedenthal Financial 0.55% 21,574 $1.1M
13 Blue Sky Capital Consultants Group, Inc. 0.50% 20,588 $1.0M
14 WESPAC Advisors, LLC 0.43% 15,577 $791K
15 QUATTRO FINANCIAL ADVISORS LLC 0.38% 25,000 $1.3M
16 Mirabaud & Cie SA 0.38% 18,366 $933K
17 Intrinsic Value Partners, LLC 0.35% 8,914 $453K
18 CREDIT INDUSTRIEL ET COMMERCIAL 0.34% 85,000 $4.3M
19 OFI INVEST ASSET MANAGEMENT 0.32% 547,881 $24.2M
20 J.P. Marvel Investment Advisors, LLC 0.32% 44,335 $2.3M
21 Privium Fund Management B.V. 0.32% 29,994 $1.5M
22 China Universal Asset Management Co., Ltd. 0.27% 70,085 $3.6M
23 Lake Hills Wealth Management, LLC 0.27% 9,346 $475K
24 Fortis Capital Advisors, LLC 0.23% 34,042 $1.7M
25 Forum Finance Group S.A. 0.23% 10,400 —
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — MODERNA INC (MRNA)

What does the Smart Money Trend signal show for MRNA?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added MRNA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for MRNA?

More sellers than buyers — 49% buying: Last quarter: 312 funds reduced or exited vs 296 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for MRNA holders?

Elite ownership — 45% AUM from top-100 funds: 42 of 628 holders are among the 100 largest funds by AUM, controlling 45% of total institutional value in MRNA. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held MRNA?

66% of holders stayed for 2+ years: 413 out of 628 hedge funds have held MRNA for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.